Suppr超能文献

[肝素治疗期间发生的致命性中心型肺栓塞:白色血栓综合征]

[Fatal central pulmonary embolism under heparin therapy: white-clot syndrome].

作者信息

Canova C R, Cantieni R, Zellweger U, Reinhart W H

机构信息

Medizinische Klinik, Kantonsspital Chur.

出版信息

Schweiz Med Wochenschr. 1997 May 3;127(18):762-5.

PMID:9221488
Abstract

A 75-year old female underwent coronary angiography for chest pain. Significant proximal stenosis of the left coronary artery was found. During the waiting time for bypass surgery, intravenous heparin treatment was established for several days because of recurrent unstable angina pectoris. 10 days after coronary angiography an acute event with chest pain, hypotension, tachycardia and a new right bundle branch block suspect for myocardial infarction occurred, which was treated with rt-PA. Fever, persistent hypotension, acute progressive renal failure and thrombocytopenia suggested septic shock, and the patient was transferred to our hospital. A pulmonary artery catheter could not be advanced beyond the main stem of the pulmonary artery. The patient died suddenly 24 hours later from acute right ventricular failure. Autopsy demonstrated multiple white clots in both pulmonary arteries. The histological finding of clots rich in leukocytes and fibrin was compatible with the diagnosis of heparin-induced thrombosis-thrombocytopenia or white clot syndrome. Heparin-induced thrombocytopenia may occur after about 5 days of treatment. Two distinct types have been described. The first type occurs in up to 25% of patients receiving heparin and is a result of temporary platelet aggregation, margination and peripheral sequestration. The less common second type of thrombocytopenia is thought to be mediated by a heparin-dependent IgG antibody inducing platelet aggregation and may be associated with thromboembolic events leading to the white clot syndrome, which is rarely reported in the literature. In these cases heparin should be stopped immediately and replaced by oral anticoagulation. Other therapies such as low molecular weight heparin, synthetic heparinoids, hirudin, fibrinolytic agents, plasmapheresis and intravenous immunoglobulins are discussed. Monitoring of the platelet count every 5 days in patients receiving heparin for any extended period should become standard medical practice to avoid potential fatal complications.

摘要

一名75岁女性因胸痛接受冠状动脉造影检查,发现左冠状动脉近端有明显狭窄。在等待搭桥手术期间,因反复出现不稳定型心绞痛,进行了数天的静脉肝素治疗。冠状动脉造影检查10天后,发生了急性事件,出现胸痛、低血压、心动过速以及新出现的疑似心肌梗死的右束支传导阻滞,遂用rt-PA进行治疗。发热、持续性低血压、急性进行性肾衰竭和血小板减少提示为感染性休克,患者被转至我院。肺动脉导管无法推进至肺动脉主干以外。患者24小时后因急性右心室衰竭突然死亡。尸检显示双侧肺动脉有多个白色血栓。富含白细胞和纤维蛋白的血栓的组织学发现与肝素诱导的血栓形成-血小板减少症或白色血栓综合征的诊断相符。肝素诱导的血小板减少症可能在治疗约5天后发生。已描述了两种不同类型。第一种类型发生在接受肝素治疗的患者中,比例高达25%,是暂时的血小板聚集、边缘化和外周扣押的结果。较不常见的第二种血小板减少症被认为是由肝素依赖性IgG抗体介导的,该抗体诱导血小板聚集,可能与导致白色血栓综合征的血栓栓塞事件有关,这在文献中很少报道。在这些情况下,应立即停用肝素,改用口服抗凝剂。还讨论了其他疗法,如低分子量肝素、合成类肝素、水蛭素、纤溶药物、血浆置换和静脉注射免疫球蛋白。对于长期接受肝素治疗的患者,每5天监测一次血小板计数应成为标准医疗实践,以避免潜在的致命并发症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验